DE60025170D1 - Diagnostisches verfahren für asthma - Google Patents

Diagnostisches verfahren für asthma

Info

Publication number
DE60025170D1
DE60025170D1 DE60025170T DE60025170T DE60025170D1 DE 60025170 D1 DE60025170 D1 DE 60025170D1 DE 60025170 T DE60025170 T DE 60025170T DE 60025170 T DE60025170 T DE 60025170T DE 60025170 D1 DE60025170 D1 DE 60025170D1
Authority
DE
Germany
Prior art keywords
test subject
asthma
diagnostic
bodily
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025170T
Other languages
English (en)
Other versions
DE60025170T2 (de
Inventor
Stan Hazen
Weikia Wu
David Schmitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cleveland Clinic Foundation
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Application granted granted Critical
Publication of DE60025170D1 publication Critical patent/DE60025170D1/de
Publication of DE60025170T2 publication Critical patent/DE60025170T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60025170T 1999-02-19 2000-02-18 Diagnostisches verfahren für asthma Expired - Lifetime DE60025170T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US253380 1999-02-19
US09/253,380 US6306576B1 (en) 1999-02-19 1999-02-19 Diagnostic methods for asthma
PCT/US2000/004253 WO2000049411A1 (en) 1999-02-19 2000-02-18 Diagnostic methods for asthma

Publications (2)

Publication Number Publication Date
DE60025170D1 true DE60025170D1 (de) 2006-02-02
DE60025170T2 DE60025170T2 (de) 2006-08-10

Family

ID=22960028

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025170T Expired - Lifetime DE60025170T2 (de) 1999-02-19 2000-02-18 Diagnostisches verfahren für asthma

Country Status (5)

Country Link
US (3) US6306576B1 (de)
EP (1) EP1159614B1 (de)
AT (1) ATE314648T1 (de)
DE (1) DE60025170T2 (de)
WO (1) WO2000049411A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034819A1 (en) * 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
GB0113188D0 (en) * 2001-05-31 2001-07-25 Osmetech Plc Method for detecting conditions
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
EP2268305A4 (de) * 2008-03-14 2011-08-03 Cleveland Clinic Foundation Verhältnis der teilchenzahl von oxidierter paraoxonase 1 zu paraoxonase 1/hdl als risikomarker für herz-kreislauf-erkrankungen
US8632986B2 (en) 2008-10-28 2014-01-21 Uladzimir A. Murauski Methods and kits for detection of toxemia
JP2013541560A (ja) 2010-10-19 2013-11-14 バテル・メモリアル・インスティテュート 組成物、抗体、喘息診断方法、及び抗体の調製方法
AU2012205337B2 (en) * 2011-01-13 2017-04-13 Expression Pathology, Inc. Bcl-2-like protein 11 SRM/MRM assay
RU2460456C1 (ru) * 2011-02-22 2012-09-10 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ДПО НГИУВ Минздравсоцразвития России) Способ диагностики обструктивных нарушений проходимости дыхательных путей у пациентов, находящихся на аппаратном дыхании
EP2817626B1 (de) 2012-02-20 2017-09-27 Uladzimir A. Murauski Verfahren zum Nachweis aktiver Malignitäten
US11249091B2 (en) 2018-02-22 2022-02-15 The Cleveland Clinic Foundation Detection of glucuronidated and 3-bromotyrosine
CN114324703B (zh) * 2021-12-27 2022-08-30 杭州朱养心药业有限公司 一种同时检测多种氨基酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1008594A (en) * 1963-07-03 1965-10-27 Nat Res Dev Process for the production of amines
US5280788A (en) * 1991-02-26 1994-01-25 Massachusetts Institute Of Technology Devices and methods for optical diagnosis of tissue
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides
US6096513A (en) * 1993-05-20 2000-08-01 Arch Development Corporation Polynucleotides encoding KAPPA opiod receptors
US5953477A (en) * 1995-11-20 1999-09-14 Visionex, Inc. Method and apparatus for improved fiber optic light management
US5773835A (en) * 1996-06-07 1998-06-30 Rare Earth Medical, Inc. Fiber optic spectroscopy
US5710248A (en) * 1996-07-29 1998-01-20 University Of Iowa Research Foundation Peptide tag for immunodetection and immunopurification
US6268220B1 (en) 1996-09-09 2001-07-31 Washington University Diagnostic method for atherosclerosis
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US6758824B1 (en) * 2000-11-06 2004-07-06 Suros Surgical Systems, Inc. Biopsy apparatus

Also Published As

Publication number Publication date
US6306576B1 (en) 2001-10-23
ATE314648T1 (de) 2006-01-15
US20050142626A1 (en) 2005-06-30
US20020048775A1 (en) 2002-04-25
DE60025170T2 (de) 2006-08-10
EP1159614B1 (de) 2005-12-28
EP1159614A4 (de) 2002-03-27
WO2000049411A1 (en) 2000-08-24
EP1159614A1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
US20090011452A1 (en) Method of Prognosis of Mental Diseases, E.G. Autism and Cerebral Palsy
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
JPH06201704A (ja) Hdlコレステロールに関する全血アッセイの改良型試験具および方法
TW200801515A (en) Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio- alzheimer's disease-specific molecular biomarkers (ADSMB)
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
JP2013515272A (ja) 上皮成長因子受容体(egfregfr)タンパク質srm/mrmアッセイ
WO2006113245B1 (en) Methods for measuring glycan levels of proteins
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
RU2008103988A (ru) Способ диагностики рассеяного склероза
DE60025170D1 (de) Diagnostisches verfahren für asthma
DE60332538D1 (de) Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen
WO2005081783A3 (en) Method for determination and quantification of radiation or genotoxin exposure
WO2007047029A3 (en) Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
WO2008007373B1 (en) Method and assay for glycosylation pattern detection related to cell state
DE69941627D1 (de) Für krebs
DE69939544D1 (de) Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung
CA2483757A1 (en) On-board control for analytical elements
KR101096487B1 (ko) 자폐증의 진단
EP1711831B1 (de) Diagnose von sepsis durch selektive bestimmung der konzentration der cu/zn superoxiddismutase (cu/zn sod) in patientenproben
CA2567300A1 (en) Method for examining interstitial cystitis
ATE302947T1 (de) Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
WO2002033420A3 (en) A urine test for the diagnosis of prion diseases
WO2010005077A1 (ja) パーキンソン病の疾患関連たんぱく質およびその使用
JP2013515271A (ja) インスリン受容体基質1(irs1)タンパク質srm/mrmアッセイ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition